Identification |
Name: | 2,6-Benzothiazolediamine,4,5,6,7-tetrahydro-N6-propyl-, (6S)- |
Synonyms: | 2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-;(S)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole;(-)-Pramipexole;Mirapexin;Oprymea;Pramipexol;Pramipexolum;SUD 919CL2Y;UNII-83619PEU5T; |
CAS: | 104632-26-0 |
Molecular Formula: | C10H17N3S |
Molecular Weight: | 302.27 |
InChI: | InChI=1/C10H17N3S/c1-2-5-12-7-3-4-8-9(6-7)14-10(11)13-8/h7,12H,2-6H2,1H3,(H2,11,13)/t7-/m1/s1 |
Molecular Structure: |
|
Properties |
Transport: | OTH |
Flash Point: | STABILITY |
Density: | 1.17 g/cm3 |
Solubility: | Appearance:white to off-white crystalline powder Transport Information: OTH Hazard Symbols:UN NO. particular:particular
|
Appearance: | white to off-white crystalline powder |
Flash Point: | STABILITY |
Usage: | (S)-Pramipexole enantiomer. A dopamine-D2-receptor agonist. Antiparkinsonian |
Safety Data |
Hazard Symbols |
|
|
|